Truvian Health Raises $74M In Funding For Automated Benchtop Blood Testing Analyzer, Pursues FDA Clearance

Truvian Health said it raised $74m in venture capital funding, which the company plans to use in part to try to secure US FDA clearance for its blood testing platform.

Investing
• Source: Shutterstock

Truvian Health announced it has raised $74m in funding for its automated benchtop blood testing analyzer, which aims to provide lab-accurate results for a comprehensive suite of routine blood tests in a single run.

The funding round was led by Wittington Ventures and Great Point Ventures with support from existing investors including DNS Capital,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Financing

More from Business